ESR1 and breast neoplasm: Indeed, the tumor growth suppressing effect of inflammasomes inhibitors was not detected in triple-negative MDA-MB-231 cells in our study (Figure S2B), suggesting a possibility that ERα signaling plays a role in the linkage between inflammasomes and breast tumor growth.